Trending Now - Hepatitis B Vaccine Delay May Lead to Surge in Infant Cases

WHO:

The Washington Post - The Trump administration is involved in the decision regarding the hepatitis B vaccine recommendations.

Truthout - The CDC (Centers for Disease Control and Prevention) is referenced as the organization making vaccine recommendations.

WHAT:

The Washington Post - The decision to drop the recommendation for newborns to receive a hepatitis B vaccine within 24 hours of birth is expected to lead to hundreds of additional infections among children.

The Washington Post - The anticipated outcomes include more cases of liver cancer, deaths, and millions in added health care costs.

WHERE:

The Washington Post - The context of the decision and its implications pertains to the United States.

WHEN:

The Washington Post - Studies published on a Monday in JAMA Pediatrics indicate the potential impact of the decision.

WHY:

Truthout - Critics argue that the CDC’s most recent vaccine recommendations are not based on science.

HOW:

The Washington Post - The change in vaccine recommendations involves dropping the long-standing guideline for administering the hepatitis B vaccine to newborns shortly after birth.

(UPDATED April 28, 2026 21:20 UTC)

The Trump administration is involved in a significant decision regarding hepatitis B vaccine recommendations, which has raised concerns among health experts. The CDC's recent choice to drop the guideline for administering the vaccine to newborns within 24 hours of birth is expected to result in hundreds of additional infections, leading to more cases of liver cancer, deaths, and increased healthcare costs in the United States. Critics argue that these recommendations are not grounded in scientific evidence, as highlighted by studies published in JAMA Pediatrics.